FRI0251 SIRUKUMAB, an ANTI-IL-6 Cytokine Monoclonal Antibody, Leads to Improvements in Work Productivity and General Health Status in Patients With Active Rheumatoid Arthritis Refractory to ANTI-TNF Therapy: Results From the Phase 3 SIRROUND-T Study

doi 10.1136/annrheumdis-2017-eular.3597
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Pms62 Association of Satisfaction With Subcutaneous Anti-TNF Therapy and Clinical Outcomes, Health Status, and Lost Work Productivity in Patients With Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

SAT0182 Sirukumab Leads to Significant and Clinically Meaningful Improvements in Health-Related Quality of Life That Meet or Exceed Normative Values in Patients With Rheumatoid Arthritis Refractory to TNF Inhibitors in Post Hoc Analyses of a Phase 3 Trial

2017English

Genetic Variant in IL-32 Is Associated With the Ex Vivo Cytokine Production of Anti-TNF Treated PBMCs From Rheumatoid Arthritis Patients

Scientific Reports
Multidisciplinary
2018English

Autoantibody Formation in Patients With Rheumatoid Arthritis Treated With Anti-TNF

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2004English

The Effects of CD20 Inhibitors Therapy in Comparison to TNF Α Inhibitors Therapy on IL-17 in Patients With Active Rheumatoid Arthritis .

IOSR Journal of Applied Chemistry
2013English

Infections in Patients With Rheumatoid Arthritis Receiving Anti-Cytokine Therapy: Biological Mechanisms and Clinical Aspects

Reumatismo
Rheumatology
2011English

Correction: Polymorphisms at Phase I-Metabolizing Enzyme and Hormone Receptor Loci Influence the Response to Anti-TNF Therapy in Rheumatoid Arthritis Patients

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2019English

Increasing Levels of Circulating Th17 Cells and Interleukin-17 in Rheumatoid Arthritis Patients With an Inadequate Response to Anti-TNF-Α Therapy

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2011English

Efficacy and Safety of Sirukumab in Japanese Patients With Moderate to Severe Rheumatoid Arthritis Inadequately Controlled by Disease Modifying Anti-Rheumatic Drugs: Subgroup Analysis of a Phase 3 Study

Modern Rheumatology
MedicineRheumatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy